Pablo Igor Ribeiro Franco

Prof. Pablo Igor Ribeiro Franco

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Pathology - Research and Practice
Verified
Journal Article
Closed access
Pablo Igor Ribeiro FrancoPablo Igor Ribeiro Franco
Pablo Igor Ribeiro Franco
ARArthur Perillo Rodrigues
Arthur Perillo Rodrigues
LMLiliana Borges de Menezes
Liliana Borges de Menezes
MMMarina Pacheco Miguel
Marina Pacheco Miguel

18 November 2022 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
Pablo Igor Ribeiro FrancoPablo Igor Ribeiro Franco
Pablo Igor Ribeiro Franco
JNJosé Rodrigues Do Carmo Neto
José Rodrigues Do Carmo Neto
AMAnália Cirqueira Milhomem
Anália Cirqueira Milhomem
JMJuliana Reis Machado
Juliana Reis Machado
MMMarina Pacheco Miguel
Marina Pacheco Miguel

Verified
Journal Article
Open access
PDF file
JNJosé Rodrigues do Carmo Neto
José Rodrigues do Carmo Neto
Pablo Igor Ribeiro FrancoPablo Igor Ribeiro Franco
Pablo Igor Ribeiro Franco
YBYarlla Loyane Lira Braga
Yarlla Loyane Lira Braga
JOJordana Fernandes de Oliveira
Jordana Fernandes de Oliveira
HPHugo Felix Perini
Hugo Felix Perini
Marcos Vinicius da SilvaMarcos Vinicius da Silva
Marcos Vinicius da Silva
Zinc oxide nanoparticles (ZnO NPs) are metal oxide nanomaterials, which are important for several applications: antibacterial, anthelmintic, antiprotozoal and antitumoral, among others. These applications are mainly related to the ability to spontaneously produce and induce the production of reactive oxygen species that are important components for the destruction of pathogens and tumor cells. While trying to potentiate ZnO NPs, studies have associated these NPs with silver oxide (AgO) or silver (Ag) NPs. It has already been reported that this combination (Ag-ZnO/AgO NPs) is able to enhance the microbicidal potential. Although possessing much potential for several purposes, it is important to evaluate whether this association also poses the risk of toxicity to cells and experimental models. Therefore, this work aimed to evaluate the toxicity of various Ag-ZnO/AgO NP nanocomposites, in vitro and in vivo. Accordingly, ZnO nanocrystals and nanocomposites with various concentrations of AgO (ZnO:5Ag, ZnO:9Ag or ZnO:11Ag) were used in different cytotoxicity models: Galleria mellonella (G. mellonella), cell lines (VERO and RAW 264.7) and C57BL/6 mice. In the G. mellonella model, four concentrations were used in a single dose, with subsequent evaluation of mortality. In the case of cells, serial concentrations starting at 125 µg/mL were used, with subsequent cytotoxicity assessment. Based on the safe doses obtained in G. mellonella and cell models, the best doses were used in mice, with subsequent evaluations of weight, biochemistry as also renal and liver histopathology. It was observed that the toxicity, although low, of the nanocomposites was dependent upon the concentration of AgO used in association with ZnO NPs, both in vitro and in vivo.

22 August 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Felipe dos Santos ArrudaFelipe dos Santos Arruda
Felipe dos Santos Arruda
FTFernanda D. Tomé
Fernanda D. Tomé
AMAnália C. Milhomem
Anália C. Milhomem
Pablo Igor Ribeiro FrancoPablo Igor Ribeiro Franco
Pablo Igor Ribeiro Franco
AJAllisson Benatti Justino
Allisson Benatti Justino
Mara Rubia Nunes CelesMara Rubia Nunes Celes
Mara Rubia Nunes Celes
Doxorubicin (DOX) is a potent chemotherapeutic agent used to treat multiple types of cancer, but its clinical application is limited by cardiotoxicity, mainly due to oxidative stress. Curcumin (CUR) is a natural polyphenolic compound with strong antioxidant properties, but its potential protective effects against DOX-induced cardiotoxicity need further investigation. This study aimed to evaluate CUR’s efficacy in mitigating DOX-induced oxidative stress in the hearts of BALB/c mice. Mice received a DOX dose of 9 mg/kg or 16 mg/kg; half of the mice received daily doses of 100 mg/kg CUR for 15 days. Survival analysis, histopathological examination, and oxidative stress markers were assessed to determine the cardioprotective effects of CUR. Results showed that CUR significantly reduced oxidative damage and improved survival rates, particularly at the lower DOX dose (9 mg/kg). Mice treated with DOX-9 mg/kg plus CUR showed improved health conditions and reduced levels of reactive oxygen species (ROS), lipid peroxidation, sulfhydryl production, and protein carbonylation. Histopathological analysis confirmed reduced cardiac tissue damage. In conclusion, CUR combined with a lower dose of DOX effectively reduces oxidative stress and cardiac injury, enhancing survival in BALB/c mice. These findings suggest that CUR is a promising adjunct therapy to mitigate DOX-induced cardiotoxicity, potentially improving the DOX therapeutic index in cancer treatment.

8 November 2022 in Biochimie
Verified
Journal Article
Closed access
Pablo Igor Ribeiro FrancoPablo Igor Ribeiro Franco
Pablo Igor Ribeiro Franco
JNJosé Rodrigues do Carmo Neto
José Rodrigues do Carmo Neto
MMMarina Pacheco Miguel
Marina Pacheco Miguel
JMJuliana Reis Machado
Juliana Reis Machado
Mara Rubia Nunes CelesMara Rubia Nunes Celes
Mara Rubia Nunes Celes

7 March 2023 in Fitoterapia
Verified
Journal Article
Closed access
RGRhanoica Oliveira Guerra
Rhanoica Oliveira Guerra
JNJosé Rodrigues do Carmo Neto
José Rodrigues do Carmo Neto
PSPriscilla Elias Ferreira da Silva
Priscilla Elias Ferreira da Silva
YBYarlla Loyane Lira Borges
Yarlla Loyane Lira Borges
Pablo Igor Ribeiro FrancoPablo Igor Ribeiro Franco
Pablo Igor Ribeiro Franco
MSMarcos Vinicius da Silva
Marcos Vinicius da Silva